Lucidio P Nunes Neto1, Guillaume Madelin1, Terlika Pandit Sood1, Chih-Chun Wu1, Douglas Kondziolka2, Dimitris Placantonakis2, John G Golfinos2, Andrew Chi3, Rajan Jain4,5. 1. Department of Radiology, New York University School of Medicine, 660 1st Avenue, New York, 10016, NY, USA. 2. Department of Neurosurgery, New York University School of Medicine, 660 1st Avenue, New York, 10016, NY, USA. 3. Department of Medicine, New York University School of Medicine, 660 1st Avenue, New York, 10016, NY, USA. 4. Department of Radiology, New York University School of Medicine, 660 1st Avenue, New York, 10016, NY, USA. rajan.jain@nyumc.org. 5. Department of Neurosurgery, New York University School of Medicine, 660 1st Avenue, New York, 10016, NY, USA. rajan.jain@nyumc.org.
Abstract
PURPOSE: Recent advances in sodium brain MRI have allowed for increased signal-to-noise ratio, faster imaging, and the ability of differentiating intracellular from extracellular sodium concentration, opening a new window of opportunity for clinical application. In gliomas, there are significant alterations in sodium metabolism, including increase in the total sodium concentration and extracellular volume fraction. The purpose of this study is to assess the feasibility of using sodium MRI quantitative measurements to evaluate gliomas. METHODS: Eight patients with treatment-naïve gliomas were scanned at 3 T with a homemade 1H/23Na head coil, generating maps of pseudo-intracellular sodium concentration (C1), pseudo-extracellular volume fraction (α2), apparent intracellular sodium concentration (aISC), and apparent total sodium concentration (aTSC). Measurements were made within the contralateral normal-appearing putamen, contralateral normal-appearing white matter (NAWM), and solid tumor regions (area of T2-FLAIR abnormality, excluding highly likely areas of edema, cysts, or necrosis). Paired samples t test were performed comparing NAWM and putamen and between NAWM and solid tumor. RESULTS: The normal-appearing putamen demonstrated significantly higher values for aTSC, aISC, C1 (p < 0.001), and α2 (p = 0.002) when compared to those of NAWM. The mean average of all solid tumors, when compared to that of NAWM, demonstrated significantly higher values of aTSC and α2 (p < 0.001), and significantly lower values of aISC (p = 0.02) for each patient. There was no significant difference between the values of C1 (p = 0.19). CONCLUSION: Quantitative sodium measurements can be done in glioma patients and also has provided further evidence that total sodium and extracellular volume fraction are increased in gliomas.
PURPOSE: Recent advances in sodium brain MRI have allowed for increased signal-to-noise ratio, faster imaging, and the ability of differentiating intracellular from extracellular sodium concentration, opening a new window of opportunity for clinical application. In gliomas, there are significant alterations in sodium metabolism, including increase in the total sodium concentration and extracellular volume fraction. The purpose of this study is to assess the feasibility of using sodium MRI quantitative measurements to evaluate gliomas. METHODS: Eight patients with treatment-naïve gliomas were scanned at 3 T with a homemade 1H/23Na head coil, generating maps of pseudo-intracellular sodium concentration (C1), pseudo-extracellular volume fraction (α2), apparent intracellular sodium concentration (aISC), and apparent total sodium concentration (aTSC). Measurements were made within the contralateral normal-appearing putamen, contralateral normal-appearing white matter (NAWM), and solid tumor regions (area of T2-FLAIR abnormality, excluding highly likely areas of edema, cysts, or necrosis). Paired samples t test were performed comparing NAWM and putamen and between NAWM and solid tumor. RESULTS: The normal-appearing putamen demonstrated significantly higher values for aTSC, aISC, C1 (p < 0.001), and α2 (p = 0.002) when compared to those of NAWM. The mean average of all solid tumors, when compared to that of NAWM, demonstrated significantly higher values of aTSC and α2 (p < 0.001), and significantly lower values of aISC (p = 0.02) for each patient. There was no significant difference between the values of C1 (p = 0.19). CONCLUSION: Quantitative sodium measurements can be done in gliomapatients and also has provided further evidence that total sodium and extracellular volume fraction are increased in gliomas.
Authors: F E Boada; C Tanase; D Davis; K Walter; A Torres-Trejo; M Couce; R Hamilton; D Kondziolka; W Bartynski; F Lieberman Journal: Conf Proc IEEE Eng Med Biol Soc Date: 2004
Authors: James G Pipe; Nicholas R Zwart; Eric A Aboussouan; Ryan K Robison; Ajit Devaraj; Kenneth O Johnson Journal: Magn Reson Med Date: 2011-04-05 Impact factor: 4.668
Authors: Michael D Blough; Mohammad Al-Najjar; Charles Chesnelong; Carmen E Binding; Alexandra D Rogers; H Artee Luchman; John J Kelly; Larry Fliegel; Olena Morozova; Stephen Yip; Marco Marra; Samuel Weiss; Jennifer A Chan; J Gregory Cairncross Journal: Ann Neurol Date: 2012-06 Impact factor: 10.422
Authors: Ben Ridley; Armin M Nagel; Mark Bydder; Adil Maarouf; Jan-Patrick Stellmann; Soraya Gherib; Jeremy Verneuil; Patrick Viout; Maxime Guye; Jean-Philippe Ranjeva; Wafaa Zaaraoui Journal: Sci Rep Date: 2018-03-12 Impact factor: 4.379
Authors: Aliaksandra Shymanskaya; Wieland A Worthoff; Gabriele Stoffels; Johannes Lindemeyer; Bernd Neumaier; Philipp Lohmann; Norbert Galldiks; Karl-Josef Langen; N Jon Shah Journal: Mol Imaging Biol Date: 2020-02 Impact factor: 3.488
Authors: Theresa K Leslie; Andrew D James; Fulvio Zaccagna; James T Grist; Surrin Deen; Aneurin Kennerley; Frank Riemer; Joshua D Kaggie; Ferdia A Gallagher; Fiona J Gilbert; William J Brackenbury Journal: Biochim Biophys Acta Rev Cancer Date: 2019-07-23 Impact factor: 10.680